Although differences in PFS for Phascolarctobacterium and Veillonella were not statistically significant, an increasing trend toward worse outcomes was observed (Fig. 5 D, E).
← all excerpts
Gut microbiome remodeling across hepatocellular carcinoma progression and transarterial chemoembolization is associated with therapeutic response and prognosis.
1
—
—